Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System

NCT00528385 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Chronic Kidney Disease
Proteinuria

Interventions

DRUG: Spironolactone (Spironol) 25 mg

Sponsor

Medical University of Gdansk